Friday, March 1, 2013

ACC filed a lawsuit to halt the state of California from including BPA on its Proposition 65 list of reproductive toxicants, noting that the state’s proposal to list BPA circumvents its own scientific process by permitting administrative staff to overturn a unanimous conclusion by the state’s own panel of scientific experts, which reviewed the same evidence and determined that BPA should not be listed under Proposition 65. The consensus of major government agencies around the world, including the U.S. Food and Drug Administration, European Food Safety Authority, Japanese National Institute of Advanced Industrial Science and Technology and the World Health Organization supports the safety of BPA in food contact materials and other consumer products.

Monday, February 18, 2013

A study published in Pediatrics found that exposures to BPA from the use of life-saving medical equipment on premature infants in the NICU were low and well within safe limits established by regulators. The findings are consistent with an earlier study from some of the same researchers, which noted that even premature infants have some capacity to process BPA. Combined with more extensive studies, the available evidence indicates that even premature infants have the capability to quickly metabolize and eliminate BPA from the body, similar to adults.

Friday, January 25, 2013

The California Office of Environmental Health Hazard Assessment published a Notice of Intent to list BPA as a developmental toxicant under Proposition 65. ACC stated that the weight of scientific evidence does not support this, and this action sharply contrasts with the results of the earlier assessment conducted by California’s own scientific experts. ACC also noted that the state proposed a “Maximum Allowable Dose Level” for BPA that is consistent with safe exposure levels cited by numerous regulatory bodies around the world and provides a sufficient margin of safety to protect consumers.

Wednesday, January 9, 2013

ACC states that an analysis of national survey data published in an online issue of Kidney International is inherently and fundamentally limited and is incapable of establishing any meaningful connection between BPA and any chronic disease because it cannot establish any cause-and-effect relationship. ACC notes that the study authors themselves cannot confirm that BPA contributes to heart disease or kidney dysfunction in children, and study did not actually measure any effects on the heart or kidneys, but only speculates about such effects.

Wednesday, January 2, 2013

French President François Hollande’s decision to restrict uses of BPA on December 24, 2012, directly contradicts government and scientific bodies around the globe. BPA is safe as used, according to FDA and Health Canada and many other regulatory bodies.

Pages